跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
KYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
KYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSION
Amgen Europe B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 9, 2025
Approval ID
b2a3e96f914f4673
Company
Amgen Europe B.V.
Type
Standard
Approval Details
Approval Id
b2a3e96f914f4673
Drug Cima Aemps Name
KYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSION
Register Number
1151060003IP1
Holder Company Name
Amgen Europe B.V.
Marketing Company Name
Orifarm A/S
Holder Company Detail Path
/organization/amgen-europe-b-v
Authorization Date
2025-09-09
Dosage Form
POLVO PARA SOLUCIÓN INYECTABLE
Dose
30 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Amgen Europe B.V.
Company Detail Path
/organization/amgen-europe-b-v
Company Information
Pharmaceutical Company Name
AMGEN EUROPE B.V.
Country Name
Israel
City Name
tel aviv-jaffa,central district,country_il
Address
Simtat Maoz
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 9, 2025
Approval ID
b2a3e96f914f4673
Type
Standard
Back to CIMA-AEMPS Approvals
KYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
